These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18191638)

  • 1. Expression of Kir 4.1 in human astrocytic tumors: correlation with pathologic grade.
    Tan G; Sun SQ; Yuan DL
    Biochem Biophys Res Commun; 2008 Mar; 367(4):743-7. PubMed ID: 18191638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
    Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
    Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
    Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L
    Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
    Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
    Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry.
    Cao L; Cao W; Zhang W; Lin H; Yang X; Zhen H; Cheng J; Dong W; Huo J; Zhang X
    Neurosci Lett; 2008 Feb; 432(2):94-9. PubMed ID: 18242847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative gliosis causes mislocation and inactivation of inwardly rectifying K(+) (Kir) channels in rabbit retinal glial cells.
    Ulbricht E; Pannicke T; Hollborn M; Raap M; Goczalik I; Iandiev I; Härtig W; Uhlmann S; Wiedemann P; Reichenbach A; Bringmann A; Francke M
    Exp Eye Res; 2008 Feb; 86(2):305-13. PubMed ID: 18078934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors.
    Mennel HD; Lell B
    Clin Neuropathol; 2005; 24(1):13-8. PubMed ID: 15696779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of EphA2 in human astrocytic tumors: correlation with pathologic grade, proliferation and apoptosis.
    Li X; Wang Y; Wang Y; Zhen H; Yang H; Fei Z; Zhang J; Liu W; Wang Y; Zhang X
    Tumour Biol; 2007; 28(3):165-72. PubMed ID: 17519535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
    Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
    Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression in childhood primary brain tumors of NY-ESO-1, a cancer/testis antigen: an immunohistochemical study.
    Bodey B; Bodey V; Siegel SE
    In Vivo; 2008; 22(1):83-7. PubMed ID: 18396787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of the expression of the RCAS1 mRNA and protein in astrocytic tumors].
    Shen CF; Yuan XR; Qin ZQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):836-9. PubMed ID: 18007080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors.
    Nakagawa T; Kabuto M; Kubota T; Kodera T; Sato K
    Anticancer Res; 1999; 19(4B):2963-8. PubMed ID: 10652580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocalyxin expression in malignant astrocytic tumors.
    Hayatsu N; Kaneko MK; Mishima K; Nishikawa R; Matsutani M; Price JE; Kato Y
    Biochem Biophys Res Commun; 2008 Sep; 374(2):394-8. PubMed ID: 18639524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas.
    Zhao Y; Xue Y; Liu Y; Fu W; Jiang N; An P; Wang P; Yang Z; Wang Y
    Br J Neurosurg; 2005 Aug; 19(4):322-6. PubMed ID: 16455538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.
    Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D
    Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors.
    Ellert-Miklaszewska A; Grajkowska W; Gabrusiewicz K; Kaminska B; Konarska L
    Brain Res; 2007 Mar; 1137(1):161-9. PubMed ID: 17239827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoA protein expression correlates positively with degree of malignancy in astrocytomas.
    Yan B; Chour HH; Peh BK; Lim C; Salto-Tellez M
    Neurosci Lett; 2006 Oct; 407(2):124-6. PubMed ID: 16978776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors.
    Blümcke I; Müller S; Buslei R; Riederer BM; Wiestler OD
    Acta Neuropathol; 2004 Aug; 108(2):89-96. PubMed ID: 15146346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.